Mary Kay Ladone is Director of Bioventus Inc.. Currently has a direct ownership of 52,488 shares of BVS, which is worth approximately $301,806. The most recent transaction as insider was on Jun 16, 2024, when has been sold 1,814 shares (Class A Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 52.5K
158.89% 3M change
158.89% 12M change
Total Value Held $301,806

Mary Kay Ladone Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 16 2024
BUY
Exercise of conversion of derivative security
-
1,814 Added 3.34%
52,488 Class A Common Stock
Jun 07 2024
BUY
Exercise of conversion of derivative security
-
30,400 Added 37.5%
50,674 Class A Common Stock
Jun 16 2023
BUY
Exercise of conversion of derivative security
-
1,813 Added 8.21%
20,274 Class A Common Stock
Jun 06 2023
BUY
Exercise of conversion of derivative security
-
16,648 Added 47.42%
18,461 Class A Common Stock
Jun 16 2022
BUY
Exercise of conversion of derivative security
-
1,813 Added 50.0%
1,813 Class A Common Stock

Also insider at

INGN
Inogen Inc Healthcare
MKL

Mary Kay Ladone

Director
Durham, NC

Track Institutional and Insider Activities on BVS

Follow Bioventus Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BVS shares.

Notify only if

Insider Trading

Get notified when an Bioventus Inc. insider buys or sells BVS shares.

Notify only if

News

Receive news related to Bioventus Inc.

Track Activities on BVS